Evidence map›Paper›PMID 27158514›Full record

ArticleJournal of pharmaceutical policy and practice2016

Using health markets to improve access to medicines: three case studies.

Zubin Shroff, Maryam Bigdeli, Zaheer-Ud-Din Babar, Anita Wagner, Abdul Ghaffar, David H Peters

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zubin ShroffAlliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.
Maryam BigdeliHealth Systems Governance, Policy and Aid Effectiveness, World Health Organization, Geneva, Switzerland.
Zaheer-Ud-Din BabarUniversity of Auckland, Auckland, New Zealand.
Anita WagnerHarvard Medical School, Boston, USA.
Abdul GhaffarAlliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.
David H PetersJohns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the added value of using a systems approach for a holistic understanding of how these interventions interact with the rest of the health system and the intended and unintended consequences that result. It goes on to summarize key findings from each of the studies and concludes with lessons for decision-makers on the design and implementation of market based interventions in LMIC health systems.

Identifiers

PMID27158514
PMCPMC4859952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.